Post by Hologic, Inc.
310,956 followers
Identifying HPV infections most likely to progress to disease starts with the right test. In a recent webinar, Hologic Medical Director Dr. Kyle Bukowski, MD, FACOG explains how the Aptima® HPV Assay finds clinically active, high-risk HPV infections by targeting E6 and E7 mRNA. The assay detects all 14 high-risk genotypes, with a targeted approach to genotypes 16, 18, and 45, which are associated with up to 92% of HPV-related cervical adenocarcinomas, helping clinicians guide more precise patient follow-up. Watch now: https://ow.ly/vSVT50ZjjQx #WomensHealth #CervicalHealth
Video Content